- Filed
- Apr 18, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Apr 17, 2025 | 110.42M sh |
| Cash And Equivalents | FY 2024 · Dec 31, 2024 | $181.52K |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $45.07K |
| Sga Expense | FY 2024 · Dec 31, 2024 | $760.3K |
| Sga Expense restated | FY 2024 · Dec 31, 2023 | $1.1M |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 17.91M sh |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$230.08K |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $1.03M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $1.03M |
| Current Assets restated | FY 2024 · Dec 31, 2023 | $126.11K |
| Total Assets restated | FY 2024 · Dec 31, 2023 | $1.33M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.05 |
| Net Income | FY 2024 · Dec 31, 2023 | −$875.46K |
| Operating Income restated | FY 2024 · Dec 31, 2023 | −$879.38K |
| Gross Profit | FY 2024 · Dec 31, 2023 | $219.08K |
| Revenue | FY 2024 · Dec 31, 2023 | $339.94K |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | −$485.97K |